페서리 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Pessary Market Size, Share & Trends Analysis Report By Type (Gellhorn, Ring, Donut), By End Use (Hospitals, Ambulatory Surgical Centers, Clinics), By Region (North America, Europe, Middle East & Africa), And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,464,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,887,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,732,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

페서리 시장 성장과 동향:

Grand View Research, Inc.의 최신 보고서에 따르면 세계 페서리 시장 규모는 2025년부터 2030년까지 연평균 4.6%의 CAGR을 기록하여 2030년까지 5억 9,050만 달러에 달할 것으로 예상됩니다.

최근 몇 년 동안 골반장기탈출증 수술에 비해 페서리에 대한 수요가 증가하고 있습니다. 간단하고 편리한 적용은 환자들 사이에서 페서리의 사용 확대에 크게 기여하고 있습니다.

미국 인구 조사국에 따르면 미국 65세 이상 여성의 수는 2030년까지 두 배로 증가하여 4,000만 명 이상에 달할 것이라고 합니다. 질 페서리는 요실금과 탈장 치료 모두에서 높은 성공률과 최소한의 합병증 비율을 가지고 있습니다. 잘 착용할 수 있다면 환자의 만족도도 높습니다.

좌식 생활습관과 생활습관병도 시장 성장에 기여할 것으로 예상됩니다. 요실금, 골반장기탈출증과 같은 질환의 유병률 증가와 노인 인구의 증가는 질 페서리에 대한 수요를 촉진하고 있습니다.

질 페서리 시장은 경쟁이 치열한 시장입니다. 시장 진입 기업 중 가장 주목할 만한 기업은 CooperSurgical, Biotique America, MedGyn입니다. 주요 기업들은 신제품 출시, 인수, 제휴를 통해 서로 경쟁 우위를 차지하기 위해 노력하고 있습니다. 예를 들어, 미국에 본사를 둔 쿠퍼서지컬(CooperSurgical)은 마이렉스 페서리 피팅 키트를 발명했습니다. 이 키트는 의사와 의사가 환자의 정확한 크기를 결정하고 그에 따라 페서리를 처방하는 데 사용할 수 있도록 설계되었습니다. 이러한 상세한 분석의 채택은 전 세계 여성 건강 관리 분야에서 초점의 큰 전환을 의미하며 시장을 발전시키고 있습니다.

페서리 시장 보고서 하이라이트

• 유형별로는 삽입과 제거가 쉬운 링형 페서리가 2024년 시장을 장악했습니다.
• 또한 병원은 환자에게 우수한 치료를 제공하는 것으로 알려져 있으며, 이러한 센터에서의 치료는 일반적으로 상환되기 때문에 도입이 촉진됩니다.
• 진료소 부문은 환자 방문 횟수 증가와 진료소의 고급 인프라로 인해 예측 기간 동안 가장 빠른 성장률을 보일 것으로 예상됩니다.
• 연구 개발 비용 증가, 의약품 개발 수요 증가, 정부의 강력한 노력, 현재 프로젝트 등으로 인해 2024년 시장은 북미가 지배적이었습니다.
• 아시아태평양은 진단 분야에서 미개척 성장 기회가 많고 골반장기탈출증 유병률이 지속적으로 증가함에 따라 가장 빠른 성장률을 기록할 것으로 예상됩니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 페서리 시장 변수, 동향, 범위

• 시장 계통 전망
  • 상부 시장 전망
  • 관련/부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 페서리 시장 분석 툴
  • 업계 분석 - Porter's Five Forces 분석
  • PESTEL 분석

제4장 페서리 시장 : 유형 추정·동향 분석

• 부문 대시보드
• 페서리 시장 : 유형 변동 분석
• 페서리 시장 : 유형별 전망
• 시장 규모와 예측과 동향 분석, 2018-2030년
• 겔혼
• 링
• 도넛
• 기타

제5장 페서리 시장 : 최종 용도 추정·동향 분석

• 부문 대시보드
• 페서리 시장 : 최종 용도 변동 분석
• 페서리 시장 : 최종 용도별 전망
• 시장 규모와 예측과 동향 분석, 2018-2030년
• 병원
• 클리닉
• 외래 수술 센터

제6장 페서리 시장 : 지역 추정·동향 분석

• 지역 대시보드
• 지역별 페서리 시장 변동 분석
• 페서리 시장 : 지역별 추정·동향 분석, 2018-2030년
• 시장 규모와 예측과 동향 분석, 2018-2030년
• 북미
  • 미국
  • 캐나다
  • 멕시코
  • 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
  • 아시아태평양
  • 일본
  • 중국
  • 인도
  • 한국
  • 호주
  • 태국
  • 라틴아메리카
  • 브라질
  • 아르헨티나
  • 중동 및 아프리카
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제7장 경쟁 구도

• 시장 진출 기업 분류
• 주요 기업 개요
  • CooperSurgical Inc.
  • Bliss GVS Pharma Limited
  • MedGyn Products, Inc.
  • Panpac Medical Corp.
  • Bioteque America Inc.
  • Personal Medical Corp.
  • Dr. Arabin GmbH &Co. KG
  • INTEGRA LIFESCIENCES

ksm

영문 목차

영문목차

Pessary Market Growth & Trends:

The global pessary market size is expected to reach USD 590.5 million by 2030, registering a CAGR of 4.6% from 2025 to 2030, according to a new report by Grand View Research, Inc. An increase in the demand for pessaries has been witnessed in recent years as compared to the surgeries performed for pelvic organ prolapse. Easy and convenient application has largely favored the growing usage of pessaries among patients.

According to the U.S. Census Bureau, the number of women aged 65 years and above in America would double by 2030 to reach over 40 million. Vaginal pessaries have a high success rate and minimal complication rate for the treatment of both incontinence and prolapse. When successfully fitted, they are associated with high patient satisfaction.

Sedentary lifestyles and lifestyle-associated diseases are also expected to contribute to market growth. The increasing prevalence of diseases such as urinary inconsistency, pelvic organ prolapse and the rising number of geriatric population is fueling the demand for vaginal pessaries.

The market for vaginal pessary is competitive. The most notable participants in the market are CooperSurgical, Biotique America, and MedGyn. Key players are involved in new product launches, acquisitions, and partnerships to gain a competitive edge over each other. For instance, CooperSurgical, based in the United States, invented the Milex Pessary Fitting Kit. The kit is designed for physicians and doctors who can use it to determine the exact size of the patient and prescribe the pessary accordingly. The introduction of these detailed analyses marks a significant shift in focus in the field of female healthcare around the world, which is propelling the market forward.

Pessary Market Report Highlights:

• In terms of type, the ring pessary segment dominated the market in 2024, since the device is easy to insert and remove
• The hospitals segment held the largest revenue share in 2024, as they are the primary point of care for treatment, furthermore, hospitals are known to offer superior care to their patients, and treatment at these centers are generally reimbursed, which drives adoption
• The clinic segment is predicted to witness the fastest growth rate over the forecast timeframe due to the increasing number of patient visits and advanced infrastructure in clinics
• North America dominated the market in 2024 due to the increasing R&D spending, rising demand for medication development, strong governmental efforts, and current projects
• Asia Pacific is expected to register the fastest growth rate owing to numerous untapped growth opportunities in diagnostics and ever-increasing prevalence of pelvic organ prolapse

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.1. Segment Definitions
  • 1.1.1. Type
  • 1.1.2. End-Use
  • 1.1.3. Regional scope
  • 1.1.4. Estimates and forecasts timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for primary interviews in North America
    • 1.3.5.2. Data for primary interviews in Europe
    • 1.3.5.3. Data for primary interviews in Asia Pacific
    • 1.3.5.4. Data for primary interviews in Latin America
    • 1.3.5.5. Data for Primary interviews in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
  • 1.6.2. Approach 1: Commodity flow approach
  • 1.6.3. Volume price analysis (Model 2)
  • 1.6.4. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. End Use outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Pessary Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising prevalence of pelvic organ prolapse (POP) and urinary incontinence
    • 3.2.1.2. Increasing awareness about women's health
    • 3.2.1.3. Technological advancements in pessary design
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Limited awareness about pessary usage
    • 3.2.2.2. Discomfort or complications such as infections with prolonged use
• 3.3. Pessary Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Pessary Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Pessary Market: Type Movement Analysis
• 4.3. Pessary Market by Type Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Gellhorn
  • 4.5.1. Gellhorn Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Ring
  • 4.6.1. Ring Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Donut
  • 4.7.1. Donut Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.8. Others
  • 4.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Pessary Market: End Use Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Pessary Market: End Use Movement Analysis
• 5.3. Pessary Market by End Use Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Hospitals
  • 5.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Clinics
  • 5.6.1. Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Ambulatory Surgery Centers
  • 5.7.1. Ambulatory Surgery Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Pessary Market: Regional Estimates & Trend Analysis

• 6.1. Regional Dashboard
• 6.2. Regional Pessary Market Movement Analysis
• 6.3. Pessary Market: Regional Estimates & Trend Analysis 2018 to 2030 for the following
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. North America
  • 6.5.1. North America Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.2. U.S.
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Competitive Scenario
    • 6.5.2.3. Regulatory Framework
    • 6.5.2.4. Reimbursement scenario
    • 6.5.2.5. U.S. Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.3. Canada
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Competitive Scenario
    • 6.5.3.3. Regulatory Framework
    • 6.5.3.4. Reimbursement scenario
    • 6.5.3.5. Canada Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.4. Mexico
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Competitive Scenario
    • 6.5.4.3. Regulatory Framework
    • 6.5.4.4. Reimbursement scenario
    • 6.5.4.5. Mexico Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.5. Europe
  • 6.5.6. Europe Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.7. UK
    • 6.5.7.1. Key Country Dynamics
    • 6.5.7.2. Competitive Scenario
    • 6.5.7.3. Regulatory Framework
    • 6.5.7.4. Reimbursement scenario
    • 6.5.7.5. UK Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.8. Germany
    • 6.5.8.1. Key Country Dynamics
    • 6.5.8.2. Competitive Scenario
    • 6.5.8.3. Regulatory Framework
    • 6.5.8.4. Reimbursement scenario
    • 6.5.8.5. Germany Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.9. France
    • 6.5.9.1. Key Country Dynamics
    • 6.5.9.2. Competitive Scenario
    • 6.5.9.3. Regulatory Framework
    • 6.5.9.4. Reimbursement scenario
    • 6.5.9.5. France Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.10. Italy
    • 6.5.10.1. Key Country Dynamics
    • 6.5.10.2. Competitive Scenario
    • 6.5.10.3. Regulatory Framework
    • 6.5.10.4. Reimbursement scenario
    • 6.5.10.5. Italy Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.11. Spain
    • 6.5.11.1. Key Country Dynamics
    • 6.5.11.2. Competitive Scenario
    • 6.5.11.3. Regulatory Framework
    • 6.5.11.4. Reimbursement scenario
    • 6.5.11.5. Spain Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.12. Denmark
    • 6.5.12.1. Key Country Dynamics
    • 6.5.12.2. Competitive Scenario
    • 6.5.12.3. Regulatory Framework
    • 6.5.12.4. Reimbursement scenario
    • 6.5.12.5. Denmark Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.13. Sweden
    • 6.5.13.1. Key Country Dynamics
    • 6.5.13.2. Competitive Scenario
    • 6.5.13.3. Regulatory Framework
    • 6.5.13.4. Reimbursement scenario
    • 6.5.13.5. Sweden Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.14. Norway
    • 6.5.14.1. Key Country Dynamics
    • 6.5.14.2. Competitive Scenario
    • 6.5.14.3. Regulatory Framework
    • 6.5.14.4. Reimbursement scenario
    • 6.5.14.5. Norway Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.15. Asia Pacific
  • 6.5.16. Asia Pacific Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.17. Japan
    • 6.5.17.1. Key Country Dynamics
    • 6.5.17.2. Competitive Scenario
    • 6.5.17.3. Regulatory Framework
    • 6.5.17.4. Reimbursement scenario
    • 6.5.17.5. Japan Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.18. China
    • 6.5.18.1. Key Country Dynamics
    • 6.5.18.2. Competitive Scenario
    • 6.5.18.3. Regulatory Framework
    • 6.5.18.4. Reimbursement scenario
    • 6.5.18.5. China Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.19. India
    • 6.5.19.1. Key Country Dynamics
    • 6.5.19.2. Competitive Scenario
    • 6.5.19.3. Regulatory Framework
    • 6.5.19.4. Reimbursement scenario
    • 6.5.19.5. India Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.20. South Korea
    • 6.5.20.1. Key Country Dynamics
    • 6.5.20.2. Competitive Scenario
    • 6.5.20.3. Regulatory Framework
    • 6.5.20.4. Reimbursement scenario
    • 6.5.20.5. South Korea Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.21. Australia
    • 6.5.21.1. Key Country Dynamics
    • 6.5.21.2. Competitive Scenario
    • 6.5.21.3. Regulatory Framework
    • 6.5.21.4. Reimbursement scenario
    • 6.5.21.5. Australia Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.22. Thailand
    • 6.5.22.1. Key Country Dynamics
    • 6.5.22.2. Competitive Scenario
    • 6.5.22.3. Regulatory Framework
    • 6.5.22.4. Reimbursement scenario
    • 6.5.22.5. Thailand Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.23. Latin America
  • 6.5.24. Latin America Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.25. Brazil
    • 6.5.25.1. Key Country Dynamics
    • 6.5.25.2. Competitive Scenario
    • 6.5.25.3. Regulatory Framework
    • 6.5.25.4. Reimbursement scenario
    • 6.5.25.5. Brazil Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.26. Argentina
    • 6.5.26.1. Key Country Dynamics
    • 6.5.26.2. Competitive Scenario
    • 6.5.26.3. Regulatory Framework
    • 6.5.26.4. Reimbursement scenario
    • 6.5.26.5. Argentina Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.27. Middle East & Africa
  • 6.5.28. Middle East & Africa Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.29. South Africa
    • 6.5.29.1. Key Country Dynamics
    • 6.5.29.2. Competitive Scenario
    • 6.5.29.3. Regulatory Framework
    • 6.5.29.4. Reimbursement scenario
    • 6.5.29.5. South Africa Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.30. Saudi Arabia
    • 6.5.30.1. Key Country Dynamics
    • 6.5.30.2. Competitive Scenario
    • 6.5.30.3. Regulatory Framework
    • 6.5.30.4. Reimbursement scenario
    • 6.5.30.5. Saudi Arabia Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.31. UAE
    • 6.5.31.1. Key Country Dynamics
    • 6.5.31.2. Competitive Scenario
    • 6.5.31.3. Regulatory Framework
    • 6.5.31.4. Reimbursement scenario
    • 6.5.31.5. UAE Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.32. Kuwait
    • 6.5.32.1. Key Country Dynamics
    • 6.5.32.2. Competitive Scenario
    • 6.5.32.3. Regulatory Framework
    • 6.5.32.4. Reimbursement scenario
    • 6.5.32.5. Kuwait Pessary Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Market Participant Categorization
• 7.2. Key Company Profiles
  • 7.2.1. CooperSurgical Inc.
    • 7.2.1.1. Company overview
    • 7.2.1.2. Financial performance
    • 7.2.1.3. Product benchmarking
    • 7.2.1.4. Strategic initiatives
  • 7.2.2. Bliss GVS Pharma Limited
    • 7.2.2.1. Company overview
    • 7.2.2.2. Financial performance
    • 7.2.2.3. Product benchmarking
    • 7.2.2.4. Strategic initiatives
  • 7.2.3. MedGyn Products, Inc.
    • 7.2.3.1. Company overview
    • 7.2.3.2. Financial performance
    • 7.2.3.3. Product benchmarking
    • 7.2.3.4. Strategic initiatives
  • 7.2.4. Panpac Medical Corp.
    • 7.2.4.1. Company overview
    • 7.2.4.2. Financial performance
    • 7.2.4.3. Product benchmarking
    • 7.2.4.4. Strategic initiatives
  • 7.2.5. Bioteque America Inc.
    • 7.2.5.1. Company overview
    • 7.2.5.2. Financial performance
    • 7.2.5.3. Product benchmarking
    • 7.2.5.4. Strategic initiatives
  • 7.2.6. Personal Medical Corp.
    • 7.2.6.1. Company overview
    • 7.2.6.2. Financial performance
    • 7.2.6.3. Product benchmarking
    • 7.2.6.4. Strategic initiatives
  • 7.2.7. Dr. Arabin GmbH & Co. KG
    • 7.2.7.1. Company overview
    • 7.2.7.2. Financial performance
    • 7.2.7.3. Product benchmarking
    • 7.2.7.4. Strategic initiatives
  • 7.2.8. INTEGRA LIFESCIENCES
    • 7.2.8.1. Company overview
    • 7.2.8.2. Financial performance
    • 7.2.8.3. Product benchmarking
    • 7.2.8.4. Strategic initiatives

관련자료